Team

 

SV Life Sciences has a team of 34 professionals, of which 27 are deal professionals focusing on our portfolio; identifying investment opportunities, structuring and executing transactions, actively working with portfolio companies on development and growth initiatives and achieving investment realizations. The remaining seven team members are finance professionals who provide essential support to the deal teams and our investors. A key strength of the SV Life Sciences team is the breadth of hands-on operational experience in venture capital investment as well as within the Life Sciences industry across operational, scientific and clinical experience.  

 

 

Managing Partners

Kate Bingham
Kate Bingham
Biotechnology
James Garvey
James Garvey
All Sectors
Tom Flynn
Tom Flynn
Healthcare
Eugene Hill
Eugene Hill
Healthcare
Paul LaViolette
Paul LaViolette
Medical Devices
Michael Ross
Michael Ross
Biotechnology

Partner

Michael Balmuth
Michael Balmuth
Healthcare
Joshua Resnick
Joshua Resnick
Biotechnology
Denise Marks
Denise Marks

Operating Partner

Hamish Cameron
Hamish Cameron
Biotechnology

Venture Partners

Houman Ashrafian
Houman Ashrafian
Therapeutics
Graham Boulnois
Graham Boulnois
Biotechnology
Daniel Burgess
Daniel Burgess
Biotechnology
Michael Carter
Michael Carter
Biotechnology
Bruce Cerullo
Bruce Cerullo
Healthcare
Tillman Gerngross
Tillman Gerngross
Biotechnology
Jim Glynn
Jim Glynn
Healthcare
David Guyer
David Guyer
Biotechnology
Tim Harris
Tim Harris
Biotechnology
Michael Mendelsohn
Michael Mendelsohn
Biotechnology
David Milne
David Milne
Medical Devices
Bob Palmisano
Bob Palmisano
Medical Devices
Bruce A Peacock
Bruce A Peacock
Biotechnology
James C. Walker
James C. Walker
Healthcare

Deal Team

Carl Culicchia
Carl Culicchia
Healthcare
Jacqueline Grant
Jacqueline Grant
Biotechnology
Elizabeth Han
Elizabeth Han
Healthcare
Greg Madden
Greg Madden
All Sectors

Finance Team

Nick Coleman
Nick Coleman
Brent Faduski
Brent Faduski
Lesley Ng
Lesley Ng
Michael Schiavo
Michael Schiavo

Dementia Discovery Fund

Further information is available at www.theDDFund.com

Laurence Barker
Laurence Barker
Biotechnology
Tetsu Maruyama
Tetsu Maruyama
Biotechnology
Carol Routledge
Carol Routledge
Biotechnology
Barbara Tate
Barbara Tate
Biotechnology


⇧ Back to top